PERE’s 2025 Life Sciences report explores emerging specialized facilities amid recalibration
After a pandemic-fueled surge in development, life sciences real estate faces rising vacancies and slower rent growth. However, opportunity is shifting to biomanufacturing and cold storage subsectors, where demand is tied to scientific progress more than market cycles. For investors willing to navigate complexity, the next phase of growth may prove longer lived than the last.
INSIDE PERE'S LIFE SCIENCES REPORT
Rethinking the life sciences sector beyond the lab
Investing in life sciences moves out of the lab and into the manufacturing site.
UBS: Europe is not the US when it comes to life sciences
While US life sciences markets cool, Europe’s policy support, talent inflows and stable demand create a resilient investment landscape, says Olafur Margeirsson, head of real estate, research and strategy, EMEA ex-DACH, at UBS.
PREVIOUS COVERAGE
The future is bright for life sciences property
In 2024, market vacancies increased with new construction delivered vacant, but this trend should reverse as demand and supply return to more manageable levels.
Pharmaceutical firms’ interest in AI brings shift in property requirements
Many R&D firms are moving from traditional lab spaces to premises that offer sufficient power and network capabilities.
Breakthrough Properties: Record funding, AI are powering the next era for life sciences
Life-changing discoveries are driving demand for research laboratories worldwide, say Breakthrough Properties’ Dan Belldegrun and Daniel D’Orazi.
Life sciences sees healthy competition from lenders
Continued demand for medical and life sciences space has investors partnering with private credit and alternative financing providers.
Core US life sciences markets receive clean bill of health
Demand is expected to return soon to the 'big three' – Boston, San Francisco and San Diego.
Understanding occupier trends vital for life sciences’ future
High supply means life sciences tenants can call the shots, so meeting evolving user needs is paramount for investors.
Life sciences sees signs of recovery
Venture capital funding is rebounding, which is driving rental growth.
JLL: Investment appetite for life sciences enters new phase
Equity investors and lenders increasingly look to the UK and continental European life sciences sector as the market continues to mature, say Chris Walters and Brad Greenway at JLL.
Investment appetite remains for life sciences real estate
Year-on-year sales volume for lab, R&D space has continued to fall, but a turnaround is expected.
LATEST NEWS
Click here to access PERE’s in-depth special reports covering a wide array of topics, plus our digital magazines.